Covovax

PTI New Delhi, May 3 Serum Institute of India's coronavirus vaccine Covovax is now available for children across the country, company CEO Adar…

Serum Institute of India’s coronavirus vaccine Covovax is now available for children across the country, company CEO Adar Poonawalla said on Tuesday.In a post on Twitter, he said Covovax, which has been developed by Novavax, “is now…

Children aged 12 to 17 years can now get the Serum Institute’s coronavirus vaccine Covovax at private centres with a provision for it being made on the CoWIN portal, official sources said on Monday. A dose of Covovax will cost Rs 900 plus…

Children aged 12 to 17 years can now get the Serum Institute's coronavirus vaccine Covovax at private centres with a provision for it being made on the CoWIN portal,…

The Standing Technical Sub-Committee of the NTAGI has recommended inclusion of the Serum Institute’s Covovax in the national COVID-19 vaccination programme for children aged 12 to 17 years, sources said on Friday. India’s drug regulator…

The COVID-19 Working Group of the NTAGI has recommended inclusion of the Serum Institute’s Covovax in the national vaccination programme for those aged 12 years and above, official sources said on Sunday. India’s drug regulator had…

Covid working group of NTAGI will review this week data of Serum Institute of India’s (SII) anti-coronavirus jab Covovax to decide whether it can be included in the national COVID-19 vaccination programme for inoculating those aged 12 years…

The Novavax vaccine is manufactured and marketed in India by SII under the brand name, Covovax. The Drugs Controller General of India (DCGI) has granted emergency use authorisation (EUA) for the Novavax and Serum Institute of India (SII)…

PTI New Delhi, March 9India’s drug regulator has granted restricted emergency use authorisation to Serum Institute’s COVID-19 vaccine Covovax for the…

The Drugs Controller General Of India has already approved Covovax for restricted use in emergency situations in adults on December 28 An expert panel of India’s central drug authority has recommended permission for conducting a phase-3…